A randomized controlled trial called STRIVE is testing whether creatine and whey protein supplements combined with strength training can reduce frailty in older adults with cirrhosis. According to Gram Research analysis, this is the first rigorous study of these supplements in cirrhosis patients, enrolling 200 older adults across all disease severity levels over 12 weeks. While results aren’t yet available, the study could establish a new, affordable treatment strategy for a vulnerable population at high risk of falls, disability, and hospitalization.

Researchers are testing whether adding creatine and whey protein supplements to an exercise program can help older adults with cirrhosis (a serious liver disease) stay stronger and healthier. Cirrhosis makes people weak and frail, leading to falls, disability, and hospitalization. This new study, called STRIVE, will enroll 200 older adults with different stages of cirrhosis to see if combining strength training with these two supplements works better than exercise alone. According to Gram Research analysis, this is one of the first studies to test these supplements in cirrhosis patients, which could open new treatment options for a vulnerable population.

Key Statistics

A 2026 randomized controlled trial called STRIVE is enrolling 200 older adults with cirrhosis to test whether creatine and whey protein supplements combined with strength training reduce frailty compared to exercise alone over 12 weeks.

The STRIVE trial includes older adults with all stages of cirrhosis (Child Pugh Class A, B, and C), making it one of the first rigorous studies to test supplements in advanced liver disease patients who were previously excluded from research.

Researchers will measure frailty using the Liver Frailty Index, which combines grip strength, walking speed, and other physical function measures, along with quality of life, physical activity, and body composition changes over the 12-week intervention period.

The Quick Take

  • What they studied: Whether adding creatine and whey protein supplements to a strength training program helps older adults with cirrhosis become stronger and less frail
  • Who participated: 200 older adults (age 60 and up) with cirrhosis at various disease stages, divided equally into two groups: one receiving supplements and one receiving a placebo (fake pill)
  • Key finding: This study is still ongoing and will measure whether the supplement group shows better improvements in muscle strength, physical activity, and overall frailty compared to the placebo group over 12 weeks
  • What it means for you: If successful, this research could provide a new, simple way to help older adults with liver disease stay stronger and avoid serious complications like falls and hospitalization. However, results won’t be available until the study is complete

The Research Details

This is a randomized controlled trial, which is the gold standard type of research for testing whether a treatment works. Researchers randomly assigned 200 older adults with cirrhosis into two equal groups. One group received strength training plus creatine and whey protein supplements for 12 weeks, while the other group received strength training plus a placebo (a fake supplement that looks identical). Before starting the main study, all participants went through a 2-week warm-up period to make sure they could stick with the exercise program.

The researchers carefully matched the groups by disease severity (using a scoring system called Child Pugh Class) and gender to make sure both groups started out similar. This matching helps ensure that any differences between groups at the end come from the supplements, not from differences in the people themselves.

The study measured many things including muscle strength, physical activity levels, quality of life, diet quality, and body composition (how much muscle versus fat each person has). The main thing they’re looking for is whether frailty (weakness and loss of function) improves more in the supplement group than the placebo group.

This research approach is important because older adults with cirrhosis are a vulnerable group that hasn’t been well-studied before. Most previous exercise studies excluded people with advanced liver disease. By including people at all disease stages and using a rigorous randomized design, researchers can determine whether these affordable, safe supplements actually help this specific population. The results could change how doctors treat frailty in cirrhosis patients.

This study has several strengths that make it reliable: it’s randomized (reducing bias), it includes a placebo control group (so we know any benefits come from the supplements, not just from exercise), and it measures multiple important outcomes rather than just one. The study is also stratified by disease severity, meaning researchers matched groups carefully. However, this is a single-center study (only one hospital), so results may not apply everywhere. The study is still in progress, so final results aren’t available yet.

What the Results Show

This study is currently ongoing and has not yet published final results. The researchers are still enrolling and following participants through the 12-week intervention period. The primary outcome they’re measuring is physical frailty using the Liver Frailty Index, a scoring system that combines grip strength, walking speed, and other measures of physical function. They will compare how much frailty improves in the supplement group versus the placebo group.

Once complete, this study will provide the first rigorous evidence about whether creatine and whey protein supplements help older adults with cirrhosis. The researchers chose these two supplements because they’re already known to help build muscle in healthy older adults and athletes, but nobody had tested them in cirrhosis patients before.

The study also measures secondary outcomes including quality of life, physical activity levels, diet quality, and changes in muscle mass and body composition. These additional measurements will help paint a complete picture of how the supplements affect overall health and function.

Beyond frailty, researchers will examine how the supplements affect quality of life using standardized questionnaires, physical activity levels using activity tracking tools, and diet quality using detailed dietary assessments. They’ll also measure body composition changes using bioelectrical impedance analysis, a safe, non-invasive method that estimates muscle and fat percentages. Waist circumference, hip circumference, and arm muscle measurements will provide additional detail about where the body changes occur.

This study fills an important gap in the research. While creatine and whey protein have been studied extensively in healthy older adults and athletes, showing benefits for muscle building and strength, these supplements have never been formally tested in cirrhosis patients. Most previous exercise studies in cirrhosis excluded people with advanced disease (Child Pugh Class B or C), but this study includes all severity levels. This makes STRIVE one of the first rigorous tests of supplementation in this vulnerable population.

Since this study is still ongoing, we don’t yet know if the supplements will actually work. The study is conducted at a single health center, so results may not apply to all hospitals or populations. The 12-week duration is relatively short, so we won’t know about long-term effects. Additionally, the study requires participants to engage in a semi-supervised exercise program, so results may not apply to people who can’t or won’t exercise regularly. Finally, cirrhosis varies widely between individuals, so some people may benefit more than others.

The Bottom Line

This study is still in progress, so no final recommendations can be made yet. However, older adults with cirrhosis who are interested in improving strength and reducing frailty should discuss exercise programs with their doctor. Once results are available, creatine and whey protein supplementation may become a recommended addition to exercise programs, but this depends on what the study finds. Confidence in recommendations will be high once this rigorous trial is complete.

This research is most relevant to older adults (age 60 and up) with cirrhosis at any disease stage, their family members, and their doctors. People on liver transplant waiting lists should particularly pay attention, as reducing frailty before transplant improves outcomes. Gastroenterologists, hepatologists, and geriatricians who care for cirrhosis patients should watch for these results. People with other liver diseases or healthy older adults may see some benefit from similar approaches, but this study specifically addresses cirrhosis.

The study is designed to show changes over 12 weeks, so if the supplements work, participants should see improvements in strength and frailty measures within that timeframe. However, building significant muscle typically takes 8 to 12 weeks of consistent training, so benefits may be modest in the short term. Long-term benefits beyond 12 weeks are unknown and would require additional research.

Frequently Asked Questions

Can creatine and whey protein help people with cirrhosis stay stronger?

The STRIVE trial is currently testing this question in 200 older adults with cirrhosis. While these supplements are known to build muscle in healthy older adults, they’ve never been formally studied in cirrhosis patients. Results should clarify whether they help this vulnerable population.

What is frailty and why does it matter in liver disease?

Frailty is extreme weakness and loss of physical function that makes people vulnerable to falls, disability, and hospitalization. Older adults with cirrhosis develop frailty at higher rates, leading to serious complications. Reducing frailty improves survival and quality of life.

How long does it take to see strength improvements from creatine and protein supplements?

Building muscle typically requires 8 to 12 weeks of consistent training combined with adequate protein intake. The STRIVE study measures changes over 12 weeks, so this is the expected timeframe for seeing meaningful improvements in strength and frailty measures.

Are creatine and whey protein safe for people with liver disease?

Both supplements are generally considered safe in healthy populations, but their safety in cirrhosis hasn’t been formally studied. The STRIVE trial will help establish safety and effectiveness. Patients should discuss any supplements with their hepatologist before starting.

Who should participate in strength training if they have cirrhosis?

Older adults with cirrhosis at any disease stage may benefit from supervised strength training, but they should get medical clearance first. The STRIVE study includes people with advanced disease, suggesting that even sicker patients can safely exercise with proper supervision and monitoring.

Want to Apply This Research?

  • Users with cirrhosis could track weekly grip strength measurements (using an inexpensive hand dynamometer), walking speed over a fixed distance, and physical activity minutes using their phone’s built-in step counter. These three measures form the basis of the Liver Frailty Index used in this study.
  • The app could remind users to take their creatine and whey protein supplements at consistent times daily, log their strength training sessions with specific exercises and weights used, and record their daily protein intake to ensure they’re meeting nutritional goals. Combining these behaviors creates the complete STRIVE intervention.
  • Users should measure and log grip strength, walking speed, and physical activity weekly. The app could generate a frailty score trend over time, showing whether these measures are improving. Users should also track any falls, hospitalizations, or changes in energy levels, which are important outcomes in cirrhosis management.

This article describes an ongoing clinical trial and does not represent final research results. Older adults with cirrhosis should not start creatine, whey protein supplements, or new exercise programs without consulting their hepatologist or primary care physician first. Cirrhosis is a serious medical condition requiring professional medical management. This information is for educational purposes only and should not replace medical advice from qualified healthcare providers. Individual responses to supplements and exercise vary significantly based on disease stage and overall health status.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Strength training intervention with creatine/whey protein supplementation vs placebo on frailty in older adults with cirrhosis (STRIVE): A Randomized Controlled Trial. , Research square (2026). PubMed 42780265 | DOI
Topics
cirrhosis frailty strength training liver disease creatine whey protein supplements older adults cirrhosis muscle weakness liver disease STRIVE trial frailty intervention liver transplant preparation